Skip to main content
. 2024 Sep 23;19(1):89. doi: 10.1007/s11657-024-01447-7

Fig. 5.

Fig. 5

Forest plot of meta-analysis result in incidence of adverse. A Teriparatide vs. bisphosphonates in incidence of adverse. B Denosumab vs. bisphosphonates in incidence of adverse